Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells (Q38977350)

8 September 2017

title

Ochratoxin A activates opposing c-MET/PI3K/Akt and MAPK/ERK 1-2 pathways in human proximal tubule HK-2 cells (English)

1 reference

8 September 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Zeynep Özcan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gizem Gül

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

8 July 2014

1 reference

8 September 2017

published in

Archives of Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

1313-1327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25002221%20AND%20SRC:MED&resulttype=core&format=json

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Immunotoxic effects of Ochratoxin A in Wistar rats after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

In vitro gene expression data supporting a DNA non-reactive genotoxic mechanism for ochratoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Signaling pathways in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Renal lesions induced by ochratoxin A exposure in the F344 rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

ERK implication in cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin a: its cancer risk and potential for exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Molecular aspects of the transport and toxicity of ochratoxin a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

MAP kinase signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

HGF-independent potentiation of EGFR action by c-Met

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Metabolism of ochratoxin A: absence of formation of genotoxic derivatives by human and rat enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Evaluation of a urinary kidney biomarker panel in rat models of acute and subchronic nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Noncatalytic function of ERK1/2 can promote Raf/MEK/ERK-mediated growth arrest signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Activating mutations for the met tyrosine kinase receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Transcriptomic alterations induced by Ochratoxin A in rat and human renal proximal tubular in vitro models and comparison to a rat in vivo model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: in utero exposure in mice induces adducts in testicular DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A and citrinin nephrotoxicity in New Zealand White rabbits: an ultrastructural assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Caspases 3 and 7: key mediators of mitochondrial events of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

p53 activation inhibits ochratoxin A-induced apoptosis in monkey and human kidney epithelial cells via suppression of JNK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

The genetic basis of kidney cancer: a metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Targeting the phosphoinositide 3-kinase pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

The role of stress-activated protein kinase signaling in renal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin a and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: lack of formation of covalent DNA adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Evidence for a role of oxidative stress in the carcinogenicity of ochratoxin a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: the continuing enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Akt (protein kinase B) negatively regulates SEK1 by means of protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Apoptosis and oxidative stress induced by ochratoxin A in rat kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: An overview on toxicity and carcinogenicity in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Acute neurotoxic effects of the fungal metabolite ochratoxin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Akt is activated in response to an apoptotic signal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Phosphorylation of the PTEN tail regulates protein stability and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Requirement for ERK activation in cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

ERK and p38 MAPK signaling pathways are involved in ochratoxin A-induced G2 phase arrest in human gastric epithelium cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Phosphoinositide 3-kinase signalling--which way to target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Receptor tyrosine kinase coactivation networks in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Proteome response to ochratoxin A-induced apoptotic cell death in mouse hippocampal HT22 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Phosphatases: the new brakes for cancer development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

A death-promoting role for extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X

Low doses of ochratoxin A upregulate the protein expression of organic anion transporters Oat1, Oat2, Oat3 and Oat5 in rat kidney cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-014-1311-X